Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amandine Crombe

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
NPJ Precision Oncology|October 7, 2024
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trialsArnaud Bayle, Laila Belcaid, Sophie Cousin, et al.
Ebiomedicine|November 30, 2020
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapiesMaud Toulmonde, Carlo Lucchesi, Stéphanie Verbeke, et al.
The Lancet. Oncology|February 21, 2020
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trialAntoine Italiano, Olivier Mir, Simone Mathoulin-Pelissier, et al.
The Lancet. Oncology|July 24, 2019
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 studyMaud Toulmonde, Marina Pulido, Isabelle Ray-Coquard, et al.
Cancer Research|June 8, 2026
Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide ImagesArianna Bonetti, Van-Linh Le, Zunamys I Carrero, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
NPJ Precision Oncology|October 7, 2024
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trialsArnaud Bayle, Laila Belcaid, Sophie Cousin, et al.
Ebiomedicine|November 30, 2020
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapiesMaud Toulmonde, Carlo Lucchesi, Stéphanie Verbeke, et al.
The Lancet. Oncology|February 21, 2020
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trialAntoine Italiano, Olivier Mir, Simone Mathoulin-Pelissier, et al.
The Lancet. Oncology|July 24, 2019
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 studyMaud Toulmonde, Marina Pulido, Isabelle Ray-Coquard, et al.
Cancer Research|June 8, 2026
Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide ImagesArianna Bonetti, Van-Linh Le, Zunamys I Carrero, et al.
Pageof 2